Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
PTPIPetros Pharmaceuticals, Inc.
| Figure | PTPIPetros Pharmaceuticals, Inc.FY2024 · Dec |
|---|---|
| Revenue | $5.11M |
| Revenue, yoy | −12.2% |
| Net income | $1.91M |
| Net income, yoy | +113.4% |
| Net margin | — |
| Free cash flow | $2.63M |
| FCF margin | -51.4% |
| EPS, diluted | $1.56 |
Add another company.
Annual · FY2020–FY2024 · USD
From SEC EDGARSame fiscal periods, as filed